World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
47630
World Ranking
6707
National Ranking
3541

Overview

Vibeke Strand is affiliated with Stanford University in the United States and has contributed extensively to the field of medicine, with particular focus on rheumatology. Their research spans a broad range of subfields including immunology, hematology, genetics, and economics and econometrics.

The main topics of Vibeke Strand's work center on rheumatoid arthritis research and therapies, spondyloarthritis studies and treatments, psoriasis treatment and pathogenesis, autoimmune and inflammatory disorders research, systemic lupus erythematosus research, chronic lymphocytic leukemia research, and health systems, economic evaluations, and quality of life.

Their recent publications demonstrate involvement in various significant studies:

  • Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled Trial, 2020, Arthritis & Rheumatology
  • Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations, 2020, Pain
  • The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems, 2021, Seminars in Arthritis and Rheumatism
  • The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases, 2020, Journal of Allergy and Clinical Immunology
  • Immunogenicity of biologic agents in rheumatology, 2020, Nature Reviews Rheumatology

Their frequent coauthors include:

  • Philip J. Mease
  • Robin Christensen
  • Joseph F. Merola
  • Dafna D. Gladman
  • Niti Goel

Most of Vibeke Strand's work has been published in notable venues such as:

  • Annals of the Rheumatic Diseases
  • Seminars in Arthritis and Rheumatism
  • The Journal of Rheumatology
  • Lara D. Veeken
  • The Lancet Rheumatology

Best Publications

  • American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    David T. Felson;David T. Felson;Jennifer J. Anderson;Jennifer J. Anderson;Maarten Boers;Claire Bombardier;Claire Bombardier

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

    T. Pham;D. van der Heijde;R. D. Altman;J. J. Anderson

  • Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III

    Nicholas Bellamy;John Kirwan;Maarten Boers;Peter Brooks

  • Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate

    Vibeke Strand;Stanley Cohen;Michael Schiff;Arthur Weaver

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Maarten Boers;John R. Kirwan;George Wells;Dorcas Beaton

  • Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Edward Keystone;Désireé Van Der Heijde;David Mason;Robert Landewé

  • Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

    Daniel E Furst;Michael H Schiff;Roy M Fleischmann;Vibeke Strand

  • OMERACT: An international initiative to improve outcome measurement in rheumatology

    Peter Tugwell;Maarten Boers;Peter Brooks;Lee Simon

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

    J Smolen;R B Landewé;P Mease;J Brzezicki

  • Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.

    Clifton O. Bingham;J. Chris Buckland-Wright;Patrick Garnero;Stanley B. Cohen

  • Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

    Joel M. Kremer;Mark C. Genovese;Grant W. Cannon;Jacques R. Caldwell

  • Novel Evidence-Based Systemic Lupus Erythematosus Responder Index

    Richard A. Furie;Michelle A. Petri;Daniel J. Wallace;Ellen M. Ginzler

  • Minimal clinically important differences: review of methods.

    George Wells;Dorcas Beaton;Beverley Shea;Maarten Boers

  • Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

    R Fleischmann;J Vencovsky;R F van Vollenhoven;D Borenstein

  • Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate

    Stanley Cohen;Grant W. Cannon;Michael Schiff;Arthur Weaver

  • Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study.

    Vlastimir Mladenovic;Zlatko Domljan;Blaz Rozman;Ivo Jajic

  • Mechanism of action for leflunomide in rheumatoid arthritis.

    Robert I. Fox;Matthias L. Herrmann;Costakis G. Frangou;Geoffrey M. Wahl

  • Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis

    John T. Sharp;Vibeke Strand;Hoi Leung;Frank Hurley

Frequent Co-Authors

Philip J. Mease
Philip J. Mease University of Washington
Peter Tugwell
Peter Tugwell University of Ottawa
Jasvinder A. Singh
Jasvinder A. Singh Veterans Health Administration
Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Peter Brooks
Peter Brooks University of Melbourne
Robin Christensen
Robin Christensen University of Southern Denmark
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Roy Fleischmann
Roy Fleischmann The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career in the USA, a range of online nursing programs can help you reach your goals faster and with more flexibility. For registered nurses seeking to advance their qualifications, exploring online rn to bsn programs without clinical requirements is a practical option. These programs can be ideal for those balancing work and study, as they remove the need for on-site clinical rotations.

Advancement in nursing often leads to doctoral degrees. If you want to fast-track your education, consider enrolling in one of the quickest dnp program options available online. For those seeking flexibility and less intensive entry requirements, many dnp programs can be completed remotely and cater to different professional backgrounds.

If you are beginning your nursing journey, online lpn program pathways can help you enter the healthcare workforce quickly. These programs are designed for those eager to start their medical careers with a shorter, focused curriculum, offering both speed and convenience.

Best Scientists Citing Vibeke Strand

Trending Scientists

Recently Published Articles